The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A.J. Byrne(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Lewis M. Watkins(UK Dementia Research Institute), Linda J. Noble‐Haeusslein(Cardiff University), Wioleta M. Zelek(UK Dementia Research Institute), Michael O‘Donovan(Cardiff University), Jacqui Nimmo(UK Dementia Research Institute), Megan Torvell(Cardiff University), Sarah M. Carpanini(UK Dementia Research Institute), Aurora Veteleanu(Cardiff University), Timothy R. Hughes(Cardiff University), Nikoleta Daskoulidou(UK Dementia Research Institute)
Cited by 11
Related Papers
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
|Nature Genetics|2013|2.4k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
|Nature|2010|812
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709